[The assessment of cellular immunity parameters in patients with breast cancer and lymphogranulomatosis during dynamic treatment].
The paper discusses the value of various immunologic techniques for the assessment of status of T-cells and their main subpopulations in patients with breast cancer and Hodgkin's disease in the course of treatment. The immunologic parameters can be used as additional criteria of relapse and grade of response as well as to roughly monitor treatment effect.
Baldueva
I A
IA
Pukhova
Zh K
ZhK
Gavrilenkova
L P
LP
Mosberger
I D
ID
D000328:Adult; D001943:Breast Neoplasms / Q000276:immunology* / Q000628:therapy; D005260:Female; D006689:Hodgkin Disease / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007111:Immunity, Cellular; D008875:Middle Aged; D015166:Monitoring, Immunologic; D009364:Neoplasm Recurrence, Local / Q000276:immunology / Q000628:therapy; D012074:Remission Induction; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
Otsenka nekotorykh parametrov kletochnogo immuniteta u bol'nykh rakom molochnoĭ zhelezy i limfogranulematozom v dinamike lecheniia.